moa glp 1 agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 receptor agonists for individualized

and having received travel expenses from Boehringer Ingelheim, Eli Lilly, Johnson & Johnson Medical Devices & Diagnostics Group Latin America, Novo Nordisk, Sanofi US Services and Zealand Pharma A/S

Gastroenterology and Hepatology 15, 625636

Approximately 50% of the global population carries H

SGLT1 is predominantly located in the small intestine, mediating dietary glucose absorption

Conclusion As newer GLP-based therapies continue to emerge, a clearer understanding of their effects on BP may inform more integrated approaches to cardiometabolic care

Yerba mat ( Ilex paraguariensis ), a traditional herbal infusion widely consumed in South America, is recognized for its rich composition of secondary metabolites such as polyphenols, flavonoids, alkaloids, and saponins [2]